Tissue Regenix raises £40m at 16.6% discount
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
EquityFollow-ons and Rights issues

Tissue Regenix raises £40m at 16.6% discount

Tissue Regenix Group, the UK regenerative medical technology company owned by IP Group, has issued £40m of shares to finance its acquisition of CellRight Technologies in the US.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article